155 related articles for article (PubMed ID: 20854387)
41. Dental and periodontal alterations in Berardinelli-Seip syndrome.
Lima DL; Montenegro Júnior RM; Fernandes VO; Barros AI; Rêgo DM
J Int Acad Periodontol; 2007 Apr; 9(2):63-7. PubMed ID: 17506386
[TBL] [Abstract][Full Text] [Related]
42. Type 2 Congenital Generalized Lipodystrophy: The Diagnosis is in Your Hands.
Montenegro RM; Fernandes VO; Penaforte Saboia JG; Montenegro APDR; Lima JG
J Pediatr; 2019 Apr; 207():257-257.e1. PubMed ID: 30579587
[No Abstract] [Full Text] [Related]
43. Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia.
Karhan AN; Zammouri J; Auclair M; Capel E; Apaydin FD; Ates F; Verpont MC; Magré J; Fève B; Lascols O; Usta Y; Jéru I; Vigouroux C
Eur J Endocrinol; 2021 Nov; 185(6):841-854. PubMed ID: 34643546
[TBL] [Abstract][Full Text] [Related]
44. Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4.
Akinci G; Topaloglu H; Akinci B; Onay H; Karadeniz C; Ergul Y; Demir T; Ozcan EE; Altay C; Atik T; Garg A
Eur J Med Genet; 2016 Jun; 59(6-7):320-4. PubMed ID: 27167729
[TBL] [Abstract][Full Text] [Related]
45. Pseudoacromegaly in congenital generalised lipodystrophy (Berardinelli-Seip syndrome).
Chakraborty PP; Datta S; Mukhopadhyay S; Chowdhury S
BMJ Case Rep; 2016 Apr; 2016():10.1136/bcr-2016-214493. PubMed ID: 27068725
[TBL] [Abstract][Full Text] [Related]
46. Early infantile cardiomyopathy and liver disease: a multisystemic disorder caused by congenital lipodystrophy.
Debray FG; Baguette C; Colinet S; Van Maldergem L; Verellen-Dumouin C
Mol Genet Metab; 2013 Jun; 109(2):227-9. PubMed ID: 23647707
[TBL] [Abstract][Full Text] [Related]
47. Congenital generalized lipodystrophy, a case report.
Wacharasindhu S; Veerakul K; Likitmaskul S; Punnakanta L; Angsusingha K; Tuchinda C; Wasant P
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():44-6. PubMed ID: 8629139
[TBL] [Abstract][Full Text] [Related]
48. Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment.
Lupsa BC; Sachdev V; Lungu AO; Rosing DR; Gorden P
Medicine (Baltimore); 2010 Jul; 89(4):245-250. PubMed ID: 20616664
[TBL] [Abstract][Full Text] [Related]
49. Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome.
Dyment DA; Gibson WT; Huang L; Bassyouni H; Hegele RA; Innes AM
Eur J Med Genet; 2014 Sep; 57(9):524-6. PubMed ID: 24980513
[TBL] [Abstract][Full Text] [Related]
50. A case of Berardinelli-Seip syndrome presenting with cirrhosis.
Wimalaratna H; Nandasiri AS
J R Coll Physicians Edinb; 2013; 43(4):309-11. PubMed ID: 24350312
[TBL] [Abstract][Full Text] [Related]
51. An unusual cause of delayed puberty: Berardinelli- Seip syndrome.
Upreti V; Dhull P; Patnaik SK; Kumar KV
J Pediatr Endocrinol Metab; 2012; 25(11-12):1157-60. PubMed ID: 23444474
[TBL] [Abstract][Full Text] [Related]
52. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
53. The influence of thiazolidinediones on adipogenesis in vitro and in vivo: potential modifiers of intramuscular adipose tissue deposition in meat animals.
Hausman GJ; Poulos SP; Pringle TD; Azain MJ
J Anim Sci; 2008 Apr; 86(14 Suppl):E236-43. PubMed ID: 17686902
[TBL] [Abstract][Full Text] [Related]
54. Successful long-term use of pioglitazone in Berardinelli-Seip lipodystrophy-associated diabetes.
Chaves C; Chaves M; Anselmo J; César R
Endocrinol Diabetes Metab Case Rep; 2021 Apr; 2021():. PubMed ID: 33880995
[TBL] [Abstract][Full Text] [Related]
55. [Genetic and metabolic description of five patients with Berardinelli-Seip syndrome].
Barra CB; Savoldelli RD; Manna TD; Kim CA; Magre J; Porta G; Setian N; Damiani D
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):54-9. PubMed ID: 21468520
[TBL] [Abstract][Full Text] [Related]
56. Clinical and molecular characterization of two Chinese patients with Type 2 congenital generalized lipodystrophy.
Chen R; Yuan X; Wang J; Zhang Y
Gene; 2017 Dec; 637():57-62. PubMed ID: 28916377
[TBL] [Abstract][Full Text] [Related]
57. Berardinelli-Seip syndrome in a 6-year-old boy.
Babu P; Sharma R; Jayaseelan E; Appachu D
Indian J Dermatol Venereol Leprol; 2008; 74(6):644-6. PubMed ID: 19171993
[TBL] [Abstract][Full Text] [Related]
58. Berardinelli Seip Congenital Lipodystrophy Syndrome: 10 Year Follow-up.
Joshi R; Sharma S
Indian Pediatr; 2019 Oct; 56(10):877-878. PubMed ID: 31724546
[TBL] [Abstract][Full Text] [Related]
59. PPAR gamma as a metabolic regulator: insights from genomics and pharmacology.
Savage DB
Expert Rev Mol Med; 2005 Jan; 7(1):1-16. PubMed ID: 15673477
[TBL] [Abstract][Full Text] [Related]
60. [Seipin/BSCL2-related motor neuron disease: Seipinopathy is a novel conformational disease associated with endoplasmic reticulum stress].
Ito D; Suzuki N
Rinsho Shinkeigaku; 2007 Jun; 47(6):329-35. PubMed ID: 17633104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
